New Campaign and Clinical Trial Results Premiere in the Q4 2025 Transthyretin Cardiomyopathy/ATTR/hATTR Market Q4 2025 gMG Market Driven by Clinical Progress and Regulatory Milestones

New post hoc analysis results from the HELIOS-B study were announced, while slides discussing the data were distributed by Alnylam. The “Knockdown” campaign also advertised Amvuttra’s efficacy, safety, and dosing.

BridgeBio touted positive new results from the ATTRibute-CM trial and the presentation of several Attruby posters at a conference. Meanwhile, the “Raise Your Expectations” theme appeared in materials marketing the brand’s efficacy, safety, dosing, and TTR stabilization.

AstraZeneca and Ionis premiered Wainua’s DTC “Shine a Light” campaign, and the HCP “Stop/Start” theme was utilized. The brand’s efficacy and safety were also promoted to both audiences, while patient-directed pieces discussed dosing and the Wainua Way program.